Literature DB >> 25960993

Giant malignant insulinoma.

Dimitrios Karavias1, Ioannis Habeos2, Ioannis Maroulis1, Christina Kalogeropoulou3, Athanasios Tsamandas4, Ioannis Chaveles1, Dionissios Karavias1.   

Abstract

Insulinomas are the most common pancreatic neuroendocrine tumors. Most insulinomas are benign, small, intrapancreatic solid tumors and only large tumors have a tendency for malignancy. Most patients present with symptoms of hypoglycemia that are relieved with the administration of glucose. We herein present the case of a 75-year-old woman who presented with an acute hypoglycemic episode. Subsequent laboratory and radiological studies established the diagnosis of a 17-cm malignant insulinoma, with local invasion to the left kidney, lymph node metastasis, and hepatic metastases. Patient symptoms, diagnostic and imaging work-up and surgical management of both the primary and the metastatic disease are reviewed.

Entities:  

Keywords:  Giant tumor; Insulinoma; PNET

Year:  2015        PMID: 25960993      PMCID: PMC4422883          DOI: 10.4174/astr.2015.88.5.289

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  9 in total

1.  Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

Authors:  H R Balon; S J Goldsmith; B A Siegel; E B Silberstein; E P Krenning; O Lang; K J Donohoe
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

Review 2.  Pancreatic endocrine tumors.

Authors:  John C Mansour; Herbert Chen
Journal:  J Surg Res       Date:  2004-07       Impact factor: 2.192

3.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

4.  NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Authors:  Aaron I Vinik; Eugene A Woltering; Richard R P Warner; Martyn Caplin; Thomas M O'Dorisio; Gregory A Wiseman; Domenico Coppola; Vay Liang W Go
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

5.  ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW.

Authors:  A O Whipple; V K Frantz
Journal:  Ann Surg       Date:  1935-06       Impact factor: 12.969

Review 6.  Pancreatic endocrine tumors.

Authors:  Kjell Oberg
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

7.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

Authors:  F J Service; M M McMahon; P C O'Brien; D J Ballard
Journal:  Mayo Clin Proc       Date:  1991-07       Impact factor: 7.616

Review 8.  Pancreatic neuroendocrine tumours.

Authors:  N Alexakis; J P Neoptolemos
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 9.  The management of insulinoma.

Authors:  O N Tucker; P L Crotty; K C Conlon
Journal:  Br J Surg       Date:  2006-03       Impact factor: 6.939

  9 in total
  3 in total

1.  Giant insulinoma: report of a case and review of published reports.

Authors:  Kazumitsu Ueda; Tetsuro Taira; Hiroyuki Hakoda; Shoko Nakata; Shinya Okata; Takeshi Nagai; Shigeo Aoki; Hideyuki Mishima; Akihiko Sako; Tsunehiko Maruyama; Minoru Okumura
Journal:  Surg Case Rep       Date:  2016-11-19

2.  Giant insulinoma in a 15-year-old man: A case report.

Authors:  Vasin Vasikasin; Jirawat Watthanatham; Prateep Napatharatip; Sumeth Termmathurapoj
Journal:  Int J Surg Case Rep       Date:  2016-05-25

3.  Concomitant existence of pheochromocytoma in a patient with multiple endocrine neoplasia type 1.

Authors:  Ryo Okada; Tatsuo Shimura; Shigeyuki Tsukida; Jin Ando; Yasuhide Kofunato; Tomoyuki Momma; Rei Yashima; Yoshihisa Koyama; Shinichi Suzuki; Seiichi Takenoshita
Journal:  Surg Case Rep       Date:  2016-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.